Valeant, Ackman offer to buy Botox maker Allergan for $47 billion - Reuters
Canada's Valeant Pharmaceuticals International Inc said on Tuesday it has partnered with activist investor Bill Ackman in an unsolicited US$47 billion bid to buy Botox maker Allergan Inc in a move to eventually become one of the world's five biggest drug companies, reports Reuters. The offer, if successful, would bring together two mid-sized pharmaceutical companies with expertise in skin care and eye care products. Ackman's Pershing Square Capital Management, Allergan's largest shareholder with a 9.7 percent stake, disclosed in a filing on Monday that it is supporting the bid.
22 April 2014•2 mins read
